Enhancing Recovery of Arm Movement in Stroke Patients (ENHANCE)

December 29, 2021 updated by: Mindy F. Levin, McGill University

ENHANCE: Enhancing Brain Plasticity for Sensorimotor Recovery in Spastic Hemiparesis

Many people who have had a stroke have problems recovering the use of their affected arm and these problems may persist for a long time. The investigators' research will test new ways to boost recovery by using non-painful brain stimulation together with training of arm movements using basic science principles. The training program will be done using the latest technology in rehabilitation such as virtual reality and robotics. The investigators will compare three groups of patients who have had a stroke. Each group will receive different combinations of brain stimulation and arm training. Another aspect of this proposal is that the investigators will do the same training programs in three different countries - Canada, Israel and India. In this way, the investigators will combine knowledge and skills to create training programs that can be applied anywhere in the world and that are not necessarily limited to high-income countries. Also, by combining expertise, the investigators will help to build the capacity to do research in India, a middle-income country that has great potential to contribute new knowledge to rehabilitation medicine.

Study Overview

Detailed Description

Training approaches based on established principles of motor learning and neural plasticity and non-invasive brain stimulation such as repetitive Transcranial Magnetic Stimulation and transcranial Direct Current Stimulation (tDCS) show promise in modulating brain activity in order to enhance upper limb (UL) motor recovery. However, the potential for recovery may still not be attained if training programs do not specifically focus on remediating motor impairment as defined by motor control science. This project is driven by a major theory of motor control (Threshold Control Theory) suggesting that rather than directly specifying motor commands to muscles, descending systems regulate spatial thresholds (STs) of reflexes to generate and control voluntary movement within specific areas of joint space. In patients with stroke, ST control is diminished leading to the appearance of muscle spasticity, weakness and abnormal muscle activation patterns during voluntary movement within well-defined spatial (angular) zones. The investigators hypothesize that recovery of voluntary motor control is tightly linked to the recovery of threshold control. The investigators propose a training program that incorporates personalized tDCS to balance cortical hypo/hyperexcitability as well as personalized movement arm reaching training based on the identification of disorders in ST.

Overall objectives of the proposal are:

  1. To test the effectiveness of personalized training programs to increase the range of regulation of STs in the elbow during reaching.
  2. To determine the effects of repetitive tDCS aimed at inhibiting excessive/exciting diminished cortical activity.
  3. To determine the feasibility of implementing personalized training programs in high and low-to-middle income countries.

Sixty patients with sub-acute (3 wks-6 mos) stroke will be recruited in this multi-site international trial taking place in Canada, Israel and India. Participants will have spasticity in the elbow flexors and/or extensors, with some active elbow control. Each site will recruit and randomize patients into one of 3 treatment groups. Group 1 will receive tDCS and practice personalized arm motor training. Group 2 will also receive tDCS with non-specific practice. Group 3 will receive Sham-tDCS and personalized practice. Training will consist of the application of tDCS in the first 30 minutes of a 50-minute arm reaching practice session,, 5 days per week for 2 weeks. Primary outcome measures (Pre, Post, Follow-up) are elbow flexor and extensor STs and related spasticity/active control zones. Secondary measures are clinical measures of UL motor activity. By accounting for the spatial structure of motor deficits, our research will benefit both researchers and clinicians by advancing our understanding of the mechanisms underlying unimpaired/impaired motor control and recovery.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montreal, Quebec, Canada, H2H2N8
        • CRIR

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. first ever cortical or cortical/subcortical stroke confirmed by MRI/CT and medically stable;
  2. sub-acute stage of stroke (3 wk to 6 mo post-stroke);
  3. arm paresis (Chedoke-McMaster Arm Scale of 2-6 /7; Gowland et al. 1993) but able to perform voluntary elbow flexion/extension of at least 30° per direction;
  4. elbow flexor and/or extensor spasticity (> 1+/4 on Modified Ashworth Scale; Ashworth 1964; Bohannon and Smith 1987);
  5. able to provide informed consent.

Exclusion Criteria:

  1. major neurological (other than stroke) / neuromuscular / orthopaedic problems or pain that may interfere with interpretation of results;
  2. major cognitive deficits (a score <20 on the Montreal Cognitive Assessment, Nasreddine et al. 2005);
  3. history of psychiatric disorders, alcohol or drug abuse, skin sensitivity, seizures, migraines, metal in cranium and other implants (cochlear, cardiac);
  4. taking medications (e.g. epileptic and psychoactive drugs) that could affect brain activity (Poreisz 2007).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: tDCS + personalized practice
Transcranial direct current stimulation and personalized arm motor training limited to active control zones, 1 hour per day, 5 days per week for 2 weeks
Application of 1.5 mA tDCS for 30 minutes
arm exercise consisting of whole arm movement within a restricted elbow range of motion
Active Comparator: tDCS + non-personalized practice
Transcranial direct current stimulation and non-personalized arm motor training spanning both active control and spasticity zones, 1 hour per day, 5 days per week for 2 weeks
Application of 1.5 mA tDCS for 30 minutes
arm exercise consisting of unrestricted whole arm movement
Sham Comparator: sham tDCS + personalized practice
Sham transcranial direct current stimulation and personalized arm motor training limited to active control zones, 1 hour per day, 5 days per week for 2 weeks
arm exercise consisting of whole arm movement within a restricted elbow range of motion
Application of sham tDCS for 30 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in active control zone of the elbow
Time Frame: 2 weeks and 1 month
Post-test and Follow-up test; measured using motion analysis system.
2 weeks and 1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Fugl-Meyer Assessment of arm impairment score
Time Frame: 2 weeks and 1 month
Post-test and Follow-up test; Score of 66 points indicates normal functioning.
2 weeks and 1 month
Change in spasticity score
Time Frame: 2 weeks and 1 month
Post-test and Follow-up test; 6 point ordinal scale
2 weeks and 1 month
Change in streamlined Wolf Motor Function Test score
Time Frame: 2 weeks and 1 month
Post-test and Follow-up test;30 point ordinal scale
2 weeks and 1 month
Change in active range of elbow extension
Time Frame: 2 weeks and 1 month
Post-test and Follow-up test; measured with a hand-held goniometer
2 weeks and 1 month
Change in straightness of elbow trajectory during a reach to grasp task
Time Frame: 2 weeks and 1 month
Post-test and Follow-up test; measured using a motion analysis system
2 weeks and 1 month
Change in speed of endpoint movement during a reach to grasp task
Time Frame: 2 weeks and 1 month
Post-test and Follow-up test; measured using a motion analysis system
2 weeks and 1 month
Change in smoothness of endpoint trajectory during a reach to grasp task
Time Frame: 2 weeks and 1 month
Post-test and Follow-up test; measured using a motion analysis system
2 weeks and 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mindy F Levin, PhD, McGill University
  • Principal Investigator: Dario G Liebermann, PhD, Tel Aviv University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Actual)

September 1, 2020

Study Completion (Actual)

December 1, 2021

Study Registration Dates

First Submitted

January 12, 2016

First Submitted That Met QC Criteria

March 28, 2016

First Posted (Estimate)

April 1, 2016

Study Record Updates

Last Update Posted (Actual)

January 3, 2022

Last Update Submitted That Met QC Criteria

December 29, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on tDCS

3
Subscribe